Dante Labs Technology Powers Over 100 Global Scientific Studies Spanning Rare Diseases, Oncology, and CRISPR Gene Editing
核心洞察
Dante Labs (搜索) has enabled more than 100 peer-reviewed scientific studies across rare diseases, transcriptomics, CRISPR gene editing, oncology, and ancient DNA analysis.
Research teams from the US, Italy, Pakistan, Malta, and other European countries selected Dante Labs (搜索) for sequencing and bioinformatics support on complex multi-omics projects.
Notable studies include Harvard Medical School research on improving NIPT through chromosomal phasing and a pan-European transcriptomic study in a Duchenne muscular dystrophy (搜索) rat model.
Dante Labs (搜索) has reached a significant milestone, with its sequencing and bioinformatics technology underpinning more than 100 global scientific studies published in peer-reviewed journals. The research spans a broad spectrum of fields including rare diseases, transcriptomics, CRISPR gene editing, oncology, and the analysis of ancient DNA samples. Scientists and academic researchers from the United States, Italy, Pakistan, Malta, and additional European countries continue to select Dante Labs for sequencing samples in these important investigations.
The company has also contributed its own publications to the scientific literature, appearing in journals such as Gene and Nature Communications.
Notable Studies Enabled by Dante Labs (搜索)
Among the more than 100 studies, several stand out for their clinical and scientific significance. Researchers at Harvard Medical School leveraged Dante Labs (搜索) technology to investigate improvements to non-invasive prenatal testing (NIPT) through chromosomal phasing, published with the DOI 10.1038/s41598-022-14049-5.
A pan-European collaboration published in Nature Scientific Reports examined the transcriptomic profile in a rat model for Duchenne muscular dystrophy (搜索) (DOI: 10.1038/s41598-025-14756-9), contributing to the understanding of this severe neuromuscular disorder.
Additionally, an International Journal of Genomics paper focused on the early diagnosis of chronic kidney disease (搜索) in Pakistan (DOI 10.1155/ijog/8868521), addressing a pressing public health challenge in the region.
Diverse Sample Types and Bioinformatics Capabilities
Approximately 80% of the published papers involved human samples. The remaining studies covered a diverse array of non-human species, including cows, camels, plants, and viruses. While human bioinformatics pipelines are widely available, the sequencing, assembly, and bioinformatics of non-human species represent a specialized niche that Dante Labs (搜索) has successfully addressed.
The company also handled studies on ancient DNA samples, a particularly delicate undertaking given that re-sampling is impossible and the sequencing laboratory must perform under exacting conditions. Trust, the company notes, is paramount in such projects.
Leadership Perspective
"US and European and Asian scientists send us complex projects for RNA, genomics and multi-omics," said Dante Labs (搜索) CEO Andrea Riposati. "We sequenced those samples, we developed special pipelines, we created population analysis tools. It is nice to see new papers being published from these samples that we sequenced and analyzed."
The achievement is notable given that consumer-facing whole genome sequencing companies or genetics laboratories rarely accelerate scientific research to the extent of enabling more than 100 research papers. All papers can be accessed through repositories such as Google Scholar, and the Dante Labs (搜索) website features a dedicated page with upcoming blog posts planned to highlight individual studies.